Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle

Nature Communications

Volumn 5, Issue , 2014, Pages

  Thorek, Daniel L J ^a,b   Ulmert, David ^b,c   Diop, Ndeye Fatou M ^d   Lupu, Mihaela E ^b   Doran, Michael G ^b   Huang, Ruimin ^b   Abou, Diane S ^a   Larson, Steven M ^b   Grimm, Jan ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c LUND UNIVERSITY   (Sweden)

^d City College of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; FERUMOXYTOL ZR 89; IRON OXIDE; NANOPARTICLE; RADIOPHARMACEUTICAL AGENT; SORBITOL; UNCLASSIFIED DRUG; MAGNETITE;

ACCURACY ASSESSMENT; ANIMAL; BIOINDICATOR; CANCER; DISEASE PREVALENCE; INVASIVE SPECIES; IRON OXIDE; NUMERICAL MODEL; PARTICULATE MATTER; SENSITIVITY ANALYSIS; TOMOGRAPHY; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AXILLARY LYMPH NODE; CHEMICAL MODIFICATION; CLINICAL EXAMINATION; CONTROLLED STUDY; CT SPECT SCANNER; DEEP TISSUE MAPPING; DRUG UPTAKE; FEMALE; INTERMETHOD COMPARISON; ISOTOPE LABELING; LAPAROSCOPY; LYMPH NODE; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC DRAINAGE; MAGNETIC FIELD; MALE; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARTICLE SIZE; POSITRON EMISSION TOMOGRAPHY; PROSTATE; PROSTATE CANCER; PURIFICATION; RADIATION DETECTION; THIN LAYER CHROMATOGRAPHY; WHOLE BODY MRI; WHOLE BODY PET; ZETA POTENTIAL; ANIMAL; DISEASE MODEL; DRAINAGE; GENETIC ENGINEERING; MULTIMODAL IMAGING; PROSTATE TUMOR; SCINTISCANNING; SURGERY; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; DRAINAGE; FERROSOFERRIC OXIDE; GENETIC ENGINEERING; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; MICE, TRANSGENIC; MULTIMODAL IMAGING; NANOPARTICLES; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS;

EID: 84892861543     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4097     Document Type: Article

References (41)

1. Alitalo, K., Tammela, T. & Petrova, T. V. Lymphangiogenesis in development and human disease. Nature 438, 946-953 (2005 (Pubitemid 43093960)
2. Carter, C. L., Allen, C. & Henson, D. E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63, 181-187 (1989 (Pubitemid 19032001)
3. Gershenwald, J. E. et al. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J. Clin. Oncol. 17, 976 (1999
4. Lucey, B. C., Stuhlfaut, J. W. & Soto, J. A. Mesenteric lymph nodes seen at imaging: Causes and significance. Radiographics 25, 351-365 (2005 (Pubitemid 40547051)
5. Pagliarulo, V. et al. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J. Clin. Oncol. 24, 2735-2742 (2006 (Pubitemid 46630570)
6. Tinga, D., Timmer, P., Bouma, J. & Aalders, J. Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol. Oncol. 39, 175-180 (1990 (Pubitemid 20372408)
7. Wilhelm, A. J., Mijnhout, G. S. & Franssen, E. J. Radiopharmaceuticals in sentinel lymph-node detection-An overview. Eur. J. Nucl. Med. 26, S36-S42 (1999 (Pubitemid 29171617)
8. Larson, S. M. & Nelp, W. B. Radiopharmacology of a simplified technetium-99m-colloid preparation for photoscanning. J. Nucl. Med. 7, 817-826 (1966
9. Scheinberg, D. A., Villa, C. H., Escorcia, F. E. & McDevitt, M. R. Conscripts of the infinite armada: Systemic cancer therapy using nanomaterials. Nat. Rev. Clin. Oncol. 7, 266-276 (2010
10. Ravizzini, G., Turkbey, B., Barrett, T., Kobayashi, H. & Choyke, P. L. Nanoparticles in sentinel lymph node mapping. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 610-623 (2009
11. Kobayashi, H et al. Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett. 7, 1711-1716 (2007 (Pubitemid 47140450)
12. Kim, C. et al. In vivo photoacoustic mapping of lymphatic systems with plasmon-resonant nanostars. J. Mater. Chem. 21, 2841-2844 (2011
13. Zhang, Q. et al. Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography. Nanotechnology 20, 395102 (2009
14. Rabin, O., Perez, J. M., Grimm, J., Wojtkiewicz, G. & Weissleder, R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat. Mater. 5, 118-122 (2006 (Pubitemid 43177900)
15. Trubetskoy, V. S., Cannillo, J. A., Milshtein, A., Wolf, G. L. & Torchilin, V. P. Controlled delivery of Gd-containing liposomes to lymph nodes: Surface modification may enhance MRI contrast properties. Magn. Reson Imaging 13, 31-37 (1995
16. Cohen, R., Vugts, D. J., Stigter-vanWalsum, M., Visser, G. W. & van Dongen, G. A. Inert coupling of IRDye800CW and zirconium-89 to monoclonal antibodies for single-or dual-mode fluorescence and PET imaging. Nat. Protoc. 8, 1010-1018 (2013
17. Brouwer, O. R. et al. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: A validation study using lymphoscintigraphy and SPECT/CT. J. Nucl. Med. 53, 1034-1040 (2012
18. Heuveling, D. A. et al. Pilot study on the feasibility of PET/CT lymphoscintigraphy with 89Zr-nanocolloidal albumin for sentinel node identification in oral cancer patients. J. Nucl. Med. 54, 585-589 (2013
19. Sondak, V. K. et al. Combined analysis of phase III trials evaluating [99mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann. Surg. Oncol. 20, 680-688 (2013
20. Harisinghani, M. G. et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348, 2491-2499 (2003 (Pubitemid 36706536)
21. McCauley, T. R., Rifkin, M. D. & Ledet, C. A. Pelvic lymph node visualization with MR imaging using local administration of ultra-small superparamagnetic iron oxide contrast. J. Magn. Reson Imaging 15, 492-497 (2002 (Pubitemid 34252414)
22. Ishiyama, K. et al. Visualization of lymphatic basin from the tumor using magnetic resonance lymphography with superparamagnetic iron oxide in patients with thoracic esophageal cancer. J. comput. Assist. Tomo. 30, 270-275 (2006 (Pubitemid 43739310)
23. Lu, M., Cohen, M. H., Rieves, D. & Pazdur, R. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am. J. Hematol. 85, 315-319 (2010
24. Cherry, S. R. Multimodality imaging: Beyond PET/CT and SPECT/CT. Semin. Nucl. Med. 39, 348-353 (2009
25. Townsend, D. Multimodality imaging of structure and function. Phys. Med. Biol. 53, R1 (2008
26. Judenhofer, M. S. et al. Simultaneous PET-MRI: A new approach for functional and morphological imaging. Nat. Med. 14, 459-465 (2008 (Pubitemid 351499385)
27. Laurent, S. et al. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064-2110 (2008
28. Kobayashi, H. et al. Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J. Natl. Cancer Inst. 96, 703-708 (2004 (Pubitemid 38660233)
29. Beattie, B. J. et al. Multimodality registration without a dedicated multimodality scanner. Mol. Imaging 6, 108-120 (2006
30. van der Poel, H. G., Buckle, T., Brouwer, O. R., Valdés Olmos, R. A. & van Leeuwen, F. W. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: Clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur. Urol. 60, 826-833 (2011
31. Van Leeuwen, A. C. et al. Tracer-cocktail injections for combined pre-And intraoperative multimodal imaging of lymph nodes in a spontaneous mouse prostate tumor model. J. Biomed. Opt. 16, 016004 (2011
32. Heuveling, D. A. et al. 89Zr-nanocolloidal albumin-based PET/CT lymphoscintigraphy for sentinel node detection in head and neck cancer: Preclinical results. J. Nucl. Med. 52, 1580-1584 (2011
33. Heuveling, D. A. et al. Nanocolloidal albumin-IRDye 800CW: A near-infrared fluorescent tracer with optimal retention in the sentinel lymph node. Eur. J. Nucl. Med. Mol. Imaging 39, 1161-1168 (2012
34. Beri, A. & Janetschek, G. Technology insight: Radioguided sentinel lymph node dissection in the staging of prostate cancer. Nat. Clin. Pract. Urol. 3, 602-610 (2006 (Pubitemid 44698095)
35. Buckle, T., Brouwer, O. R., Olmos, R. A. V., van der Poel, H. G. & van Leeuwen, F. W. Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients. J. Nucl. Med. 53, 1026-1033 (2012
36. Seo, Y. et al. Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT. J. Nucl. Med. 52, 1068-1072 (2011
37. Thorek, D. L. & Tsourkas, A. Size charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29, 3583-3590 (2008
38. Vosjan, M. J. et al. Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine. Nat. Protoc. 5, 739-743 (2010
39. McAuliffe, M. J. et al. Medical image processing, analysis and visualization in clinical research. In: IEEE Comp Med Syst. p 381 (2001
40. Qi, J., Leahy, R. M., Cherry, S. R., Chatziioannou, A. & Farquhar, T. H. Highresolution 3D Bayesian image reconstruction using the microPET small-Animal scanner. Phys. Med. Biol. 43, 1001 (1998
41. Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676-682 (2012